LQDA, FLXS, ELMD and AGX combine low beta, positive price momentum and strong fundamentals to help investors navigate market volatility.

zacks.com - 2026-07-10 12:17:10

Electromed (ELMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

zacks.com - 2026-07-06 09:56:46

If you are looking for stocks that are well positioned to maintain their recent uptrend, Electromed (ELMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

zacks.com - 2026-06-19 09:56:12

Electromed is rated 'buy' due to accelerating growth, margin expansion, and a large underpenetrated bronchiectasis market. ELMD benefits from a new CMS rule and a recently approved bronchiectasis drug, both driving increased disease awareness and streamlined clinician adoption. Gross margin improved to 78.5%, operating margin rose to 20.4%, and net income reached a record $3.0 million in Q3 FY 2026.

seekingalpha.com - 2026-06-13 09:44:19

Electromed (ELMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

zacks.com - 2026-06-03 13:46:05

GOLD, ELMD and TPR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 2nd, 2026.

zacks.com - 2026-06-02 11:00:20

GOLD, ELMD, TPR, PLGO and CRGY have been added to the Zacks Rank #1 (Strong Buy) List on June 2nd, 2026.

zacks.com - 2026-06-02 07:16:05

Electromed (ELMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

zacks.com - 2026-06-01 10:16:17

GenAI is reshaping medical instruments as Electromed, Globus Medical and Intuitive Surgical navigate M&A and market pressures.

zacks.com - 2026-05-21 14:35:20

Electromed, Inc. (ELMD) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ELMD's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.

zacks.com - 2026-05-19 10:55:44

Electromed (ELMD) possesses solid growth attributes, which could help it handily outperform the market.

zacks.com - 2026-05-18 13:46:08

Electromed (ELMD) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

zacks.com - 2026-05-15 09:55:32

HCSG, ELMD, UMBF, SHEL and MTSI passed an efficiency screen based on turnover ratios, asset use and operating margin strength.

zacks.com - 2026-05-15 09:46:34

Electromed (ELMD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

zacks.com - 2026-05-14 13:00:53

Electromed, Inc. (ELMD) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.21 per share a year ago.

zacks.com - 2026-05-12 20:01:14

Electromed, Inc. (ELMD) Q3 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-12 18:50:44

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Record Financial Performance in Fiscal 2026 Third Quarter.

businesswire.com - 2026-05-12 16:05:00

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Report Q3 Fiscal 2026 Financial Results on May 12, 2026.

businesswire.com - 2026-04-28 16:04:00